Monte Rosa Therapeutics (GLUE) Earnings Analysis
Monte Rosa Therapeutics (GLUE) has no confirmed upcoming earnings date. In its last reported quarter (2026-05-07) GLUE missed analyst consensus (-60.7% EPS surprise). Trailing P/E -12.79.
Last updated 2026-07-23 · Source: company filings + earnings calendar; consensus from sell-side analyst grades
When does GLUE next report earnings?
No confirmed upcoming earnings date is currently scheduled for GLUE. This page updates as the calendar is published.
GLUE last-quarter earnings result
| Last reported quarter | 2026-05-07 |
|---|---|
| Result vs consensus | Miss (-60.7% EPS surprise) |
GLUE consensus estimates and analyst view
Consensus estimates, 8-quarter history and analyst targets are in the SniperIQ app. Create a free account to see them.
Related research pages
More on GLUE
Frequently asked questions
When does GLUE next report earnings?
GLUE has no confirmed upcoming earnings date right now; this page updates as the calendar is published.
Did GLUE beat earnings last quarter?
In its 2026-05-07 report, GLUE missed analyst consensus (-60.7% EPS surprise).
Where can I see GLUE analyst estimates and price targets?
Consensus estimates, 8-quarter history and analyst targets for GLUE are in the SniperIQ app: https://app.sniperiq.ai/register